Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico

Detalhes bibliográficos
Ano de defesa: 2004
Autor(a) principal: Tácito, Lúcia Helena Bonalume lattes
Orientador(a): Souza, Dorotéia Rossi Silva lattes
Banca de defesa: Maranhao, Raul Cavalcante lattes, Fonseca, Francisco Antonio Helfenstein lattes, Pires, Antônio Carlos
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Faculdade de Medicina de São José do Rio Preto
Programa de Pós-Graduação: Programa de Pós-Graduação em Ciências da Saúde
Departamento: Faculdade 1::Departamento 1
País: Brasil
Palavras-chave em Português:
Palavras-chave em Inglês:
Área do conhecimento CNPq:
Link de acesso: http://bdtd.famerp.br/handle/tede/524
Resumo: Coronary artery disease (CAD) affects women, especially after menopause. Risk factors include age, familial history (FH), smoking, diabetes mellitus, systemic arterial hypertension (SAH), hyperlipidemia and obesity, and postprandial triglycerides. Apolipoprotein E (apo E), represented by 2, 3 and 4, influences lipid serous levels.The aim was to evaluate risk factors for CAD, the prevalence of alleles and genotypes of apo E and their influence on the lipid profile, and the triglyceride metabolic kinetics after a lipid-rich diet considering their association with apo E polymorphisms in women with and without CAD. A total of 180 post-menopausal women, divided into CAD and control groups, with mean ages of 60.7±5.8 and 60.7±5.5, respectively were evaluated. The weight, height, body mass index, systemic arterial pressure, FH, smoking and medicines taken of all the participants were evaluated. Venous blood samples were drawn to measure the total cholesterol (TC), low-density (LDLc), high-density (HDLc) and very low-density (VLDLc) lipoprotein cholesterol fractions and triglycerides during fasting at 3 to 6 hours after the ingestion of a single high-lipid meal. Both groups were subdivided according to levels of TC: ≤200 mg/dL; 201-239 mg/dL and ≥ 240 mg/dL. The genomic DNA was extracted from leukocytes and submitted to amplification by polymerase chain reaction, followed by polymorphism analysis using restriction fragment sizes. Comparing the CAD and control groups, there was significant association of the disease with FH (70% and 44.4% respectively; p<0.0001) and with SAH (76% and 44.4% respectively; p<0.0001). The 4 allele presented with a higher frequency in patients (0.15) compared to controls (0.07; p=0282). There were also increases in CT, LDLc and VLDLc serum levels in patients (25965.7; 170.660.1; 38.621.1mg/dL, respectively) in respect to controls 227.542.3; 136.036.9; 30.717.2mg/dL; P<0.0001; P<0.0001; P=0.025 (respectively). The mean concentration of HDLc, on the other hand, was lower in patients (50.212.0 mg/dL) compared to controls (56.516.7 mg/dL; p=0.0091). The mean triglycerides level was higher in patients and controls compared to normal levels (197113.8; 168.093.0, respectively; P=0.056). The lipid profile was not associated to apo E polymorphisms in patients. The control group with -/4 genotypes presented lower triglyceride serous levels in relation to 3/3 (131.249.9; 174.698.6 mg/dL, respectively; P=0.02). There was an increase in the HDLc serous levels of controls compared to patients, when considering the -/4 genotypes. The controls demonstrated significantly lower triglyceride levels (246.0162.8 mg/dL) compared to patients (292.2161.4 mg/dL; P<0.05), 3 to 6 hours after the lipid-rich diet, associated with the -/4 genotypes. In conclusion, FH and SAH are associated with CAD in post-menopausal women. The 4 allele is more prevalent in post-menopausal CAD patients than in control individuals, but it does not influence the lipid profile, however, it exerts a protector effect by its association with high HDLc levels in post-menopausal women without the disease. The triglyceride kinetics, although with similar profiles in both groups, reveal an association between the 4 allele and the accelerated removal of triglycerides only in the control group, suggesting a protector effect in the postprandial stage in post-menopausal women.
id FMRP_2825751e4685542928967feb014d7962
oai_identifier_str oai:localhost:tede/524
network_acronym_str FMRP
network_name_str Biblioteca Digital de Teses e Dissertações da FAMERP
repository_id_str
spelling Souza, Dorotéia Rossi Silvahttp://lattes.cnpq.br/3955257093624671Maranhao, Raul Cavalcantehttp://lattes.cnpq.br/5014918663341911Fonseca, Francisco Antonio HelfensteinPires, Antônio Carloshttp://lattes.cnpq.br/828159142327161409812657827http://lattes.cnpq.br/0060056266508363Tácito, Lúcia Helena Bonalume2019-03-07T19:00:20Z2004-05-28Tácito, Lúcia Helena Bonalume. Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico. 2004. 94 f. Tese (Programa de Pós-Graduação em Ciências da Saúde) - Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto.775http://bdtd.famerp.br/handle/tede/524Coronary artery disease (CAD) affects women, especially after menopause. Risk factors include age, familial history (FH), smoking, diabetes mellitus, systemic arterial hypertension (SAH), hyperlipidemia and obesity, and postprandial triglycerides. Apolipoprotein E (apo E), represented by 2, 3 and 4, influences lipid serous levels.The aim was to evaluate risk factors for CAD, the prevalence of alleles and genotypes of apo E and their influence on the lipid profile, and the triglyceride metabolic kinetics after a lipid-rich diet considering their association with apo E polymorphisms in women with and without CAD. A total of 180 post-menopausal women, divided into CAD and control groups, with mean ages of 60.7±5.8 and 60.7±5.5, respectively were evaluated. The weight, height, body mass index, systemic arterial pressure, FH, smoking and medicines taken of all the participants were evaluated. Venous blood samples were drawn to measure the total cholesterol (TC), low-density (LDLc), high-density (HDLc) and very low-density (VLDLc) lipoprotein cholesterol fractions and triglycerides during fasting at 3 to 6 hours after the ingestion of a single high-lipid meal. Both groups were subdivided according to levels of TC: ≤200 mg/dL; 201-239 mg/dL and ≥ 240 mg/dL. The genomic DNA was extracted from leukocytes and submitted to amplification by polymerase chain reaction, followed by polymorphism analysis using restriction fragment sizes. Comparing the CAD and control groups, there was significant association of the disease with FH (70% and 44.4% respectively; p<0.0001) and with SAH (76% and 44.4% respectively; p<0.0001). The 4 allele presented with a higher frequency in patients (0.15) compared to controls (0.07; p=0282). There were also increases in CT, LDLc and VLDLc serum levels in patients (25965.7; 170.660.1; 38.621.1mg/dL, respectively) in respect to controls 227.542.3; 136.036.9; 30.717.2mg/dL; P<0.0001; P<0.0001; P=0.025 (respectively). The mean concentration of HDLc, on the other hand, was lower in patients (50.212.0 mg/dL) compared to controls (56.516.7 mg/dL; p=0.0091). The mean triglycerides level was higher in patients and controls compared to normal levels (197113.8; 168.093.0, respectively; P=0.056). The lipid profile was not associated to apo E polymorphisms in patients. The control group with -/4 genotypes presented lower triglyceride serous levels in relation to 3/3 (131.249.9; 174.698.6 mg/dL, respectively; P=0.02). There was an increase in the HDLc serous levels of controls compared to patients, when considering the -/4 genotypes. The controls demonstrated significantly lower triglyceride levels (246.0162.8 mg/dL) compared to patients (292.2161.4 mg/dL; P<0.05), 3 to 6 hours after the lipid-rich diet, associated with the -/4 genotypes. In conclusion, FH and SAH are associated with CAD in post-menopausal women. The 4 allele is more prevalent in post-menopausal CAD patients than in control individuals, but it does not influence the lipid profile, however, it exerts a protector effect by its association with high HDLc levels in post-menopausal women without the disease. The triglyceride kinetics, although with similar profiles in both groups, reveal an association between the 4 allele and the accelerated removal of triglycerides only in the control group, suggesting a protector effect in the postprandial stage in post-menopausal women.A doença arterial coronariana (DAC) atinge mulheres, principalmente após a menopausa. Fatores de risco incluem idade, história familial (HF), tabagismo, diabetes melito, hipertensão arterial (HAS), hiperlipidemia e obesidade. Na pós-menopausa, o perfil lipídico está sujeito a alterações. O nível de TG pós-prandial está associado a DAC, sendo mais importante que no jejum para a aterogênese. A apoE e suas isoformas têm papel etiológico no desenvolvimento da aterosclerose, estando o fenótipo E3/E4 associado com DAC em relação a E2E3 e E3/E3. Os objetivos deste estudo foram identificar fatores de risco para DAC na pós-menopausa, analisar prevalência de alelos e genótipos para apoE e sua influência no perfil lipídico, e avaliar cinética do metabolismo de TG após dieta-teste rica em lipídios e sua associação com polimorfismo genético da apoE em mulheres com ou sem DAC. Foram estudadas 180 mulheres em pós-menopausa, distribuídas em dois grupos conforme presença ou ausência de DAC (idade = 60,75,8 e 60,75,5 anos, respectivamente). Foram coletadas amostras de sangue venoso para dosagens de CT, LDLc, HDLc e TG de jejum de 12 horas, 3 e 6 horas após ingestão de dose única de dieta lipídica, correspondente a 50g de gordura/m2 de superfície corporal. Ambos os grupos foram subdivididos de acordo com os níveis de CT ( 200mg/dL, = 201-239mg/dL e 240mg/dL). O DNA foi extraído de leucócitos de sangue periférico coletado com EDTA e analisados por eletroforese em gel de poliacrilamida. Dentre os fatores de risco apenas HF (70%) e HAS (76%) associaram-se a DAC, enquanto controles mostraram 44,4 e 44,4%, de freqüência respectivamente; (P<0,0001). O alelo 4 mostrou freqüência significantemente mais elevada nas pacientes (0,15) em relação aos controles (0,07; P=0,0282). Houve aumento significante nos níveis de CT, LDLc e VLDLc nas pacientes (25965,7; 170,660,1; 38,621,1mg/dL, respectivamente) em relação aos controles (227,542,3; 136,036,9; 30,717,2mg/dL; P<0,0001; P<0,0001; P=0,025, respectivamente). A concentração média de HDLc, por outro lado, mostrou-se reduzida nas pacientes (50,212,0mg/dL) comparado aos controles (56,516,7mg/dL; P=0,0091). Os níveis de TG de jejum mantiveram-se aumentados em pacientes e controles (197113,8; 168,093,0, respectivamente; P=0,056). No polimorfismo da apoE, considerando os genótipos 3/3 e -/4, não houve diferença significante em relação à CT, LDLc, HDLc, VLDLc e TG nas pacientes. Os controles portadores do genótipo -/4 apresentaram menor valor de TG relação aos 3/3 (131,249,9; 174,698,6mg/dL, respectivamente), embora sem diferença significante. Houve aumento nos níveis de HDLc nos controles em relação aos pacientes considerando-se genótipos -/4. Na fase pós-prandial os controles mostraram redução significante nos valores de TG (246,0162,8mg/dL) em relação ao grupo DAC (292,2161,4mg/dL; P<0,05) após 6 horas, sendo essa redução associada ao genótipo -/4. Portanto, hipertensão e história familial associam-se a DAC na pós-menopausa. O alelo 4 da apoE, embora mais prevalente em pacientes com DAC nessa fase, não influencia seu perfil lipídico, entretanto, parece desempenhar efeito protetor ao associar-se a níveis elevados de HDLc apenas em mulheres sem a doença. A cinética de TG, semelhante em ambos os grupos, revela associação entre alelo 4 e remoção acelerada de TG nos controles, sugerindo efeito protetor na fase pós-prandial de mulheres na pós-menopausa.Submitted by Suzana Dias (suzana.dias@famerp.br) on 2019-03-07T19:00:20Z No. of bitstreams: 1 LúciaHelenaBonalumeTácito_tese.pdf: 1292556 bytes, checksum: b71731ff47224235ecb9ee7e49a4ef01 (MD5)Made available in DSpace on 2019-03-07T19:00:20Z (GMT). No. of bitstreams: 1 LúciaHelenaBonalumeTácito_tese.pdf: 1292556 bytes, checksum: b71731ff47224235ecb9ee7e49a4ef01 (MD5) Previous issue date: 2004-05-28Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESPapplication/pdfporFaculdade de Medicina de São José do Rio PretoPrograma de Pós-Graduação em Ciências da SaúdeFAMERPBrasilFaculdade 1::Departamento 1EndocrinologiaDoença da Artéria CoronarianaApolipoproteínas EMenopausaPeríodo Pós-PrandialEndocrinologyCoronary Artery DiseaseApolipoproteins EMenopausePostprandial PeriodCIENCIAS DA SAUDE::MEDICINADoença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídicoinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis-6954410853678806574500500600600306626487509624506-969369452308786627-6491868300948288337info:eu-repo/semantics/openAccessreponame:Biblioteca Digital de Teses e Dissertações da FAMERPinstname:Faculdade de Medicina de São José do Rio Preto (FAMERP)instacron:FAMERPLICENSElicense.txtlicense.txttext/plain; charset=utf-82165bd3efa91386c1718a7f26a329fdcb468MD51ORIGINALLúciaHelenaBonalumeTácito_tese.pdfLúciaHelenaBonalumeTácito_tese.pdfapplication/pdf1292556b71731ff47224235ecb9ee7e49a4ef01MD52http://bdtd.famerp.br/bitstream/tede/524/1/license.txthttp://bdtd.famerp.br/bitstream/tede/524/2/L%C3%BAciaHelenaBonalumeT%C3%A1cito_tese.pdftede/5242019-03-07 16:00:20.609oai:localhost: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Biblioteca Digital de Teses e Dissertaçõeshttp://bdtd.famerp.br/PUBhttps://bdtd.famerp.br/oai/requestsbdc@famerp.br||joao.junior@famerp.bropendoar:47112019-03-07T19:00:20Biblioteca Digital de Teses e Dissertações da FAMERP - Faculdade de Medicina de São José do Rio Preto (FAMERP)false
dc.title.por.fl_str_mv Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
title Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
spellingShingle Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
Tácito, Lúcia Helena Bonalume
Endocrinologia
Doença da Artéria Coronariana
Apolipoproteínas E
Menopausa
Período Pós-Prandial
Endocrinology
Coronary Artery Disease
Apolipoproteins E
Menopause
Postprandial Period
CIENCIAS DA SAUDE::MEDICINA
title_short Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
title_full Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
title_fullStr Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
title_full_unstemmed Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
title_sort Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico
author Tácito, Lúcia Helena Bonalume
author_facet Tácito, Lúcia Helena Bonalume
author_role author
dc.contributor.advisor1.fl_str_mv Souza, Dorotéia Rossi Silva
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/3955257093624671
dc.contributor.referee1.fl_str_mv Maranhao, Raul Cavalcante
dc.contributor.referee1Lattes.fl_str_mv http://lattes.cnpq.br/5014918663341911
dc.contributor.referee2.fl_str_mv Fonseca, Francisco Antonio Helfenstein
dc.contributor.referee3.fl_str_mv Pires, Antônio Carlos
dc.contributor.referee3Lattes.fl_str_mv http://lattes.cnpq.br/8281591423271614
dc.contributor.authorID.fl_str_mv 09812657827
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/0060056266508363
dc.contributor.author.fl_str_mv Tácito, Lúcia Helena Bonalume
contributor_str_mv Souza, Dorotéia Rossi Silva
Maranhao, Raul Cavalcante
Fonseca, Francisco Antonio Helfenstein
Pires, Antônio Carlos
dc.subject.por.fl_str_mv Endocrinologia
Doença da Artéria Coronariana
Apolipoproteínas E
Menopausa
Período Pós-Prandial
topic Endocrinologia
Doença da Artéria Coronariana
Apolipoproteínas E
Menopausa
Período Pós-Prandial
Endocrinology
Coronary Artery Disease
Apolipoproteins E
Menopause
Postprandial Period
CIENCIAS DA SAUDE::MEDICINA
dc.subject.eng.fl_str_mv Endocrinology
Coronary Artery Disease
Apolipoproteins E
Menopause
Postprandial Period
dc.subject.cnpq.fl_str_mv CIENCIAS DA SAUDE::MEDICINA
description Coronary artery disease (CAD) affects women, especially after menopause. Risk factors include age, familial history (FH), smoking, diabetes mellitus, systemic arterial hypertension (SAH), hyperlipidemia and obesity, and postprandial triglycerides. Apolipoprotein E (apo E), represented by 2, 3 and 4, influences lipid serous levels.The aim was to evaluate risk factors for CAD, the prevalence of alleles and genotypes of apo E and their influence on the lipid profile, and the triglyceride metabolic kinetics after a lipid-rich diet considering their association with apo E polymorphisms in women with and without CAD. A total of 180 post-menopausal women, divided into CAD and control groups, with mean ages of 60.7±5.8 and 60.7±5.5, respectively were evaluated. The weight, height, body mass index, systemic arterial pressure, FH, smoking and medicines taken of all the participants were evaluated. Venous blood samples were drawn to measure the total cholesterol (TC), low-density (LDLc), high-density (HDLc) and very low-density (VLDLc) lipoprotein cholesterol fractions and triglycerides during fasting at 3 to 6 hours after the ingestion of a single high-lipid meal. Both groups were subdivided according to levels of TC: ≤200 mg/dL; 201-239 mg/dL and ≥ 240 mg/dL. The genomic DNA was extracted from leukocytes and submitted to amplification by polymerase chain reaction, followed by polymorphism analysis using restriction fragment sizes. Comparing the CAD and control groups, there was significant association of the disease with FH (70% and 44.4% respectively; p<0.0001) and with SAH (76% and 44.4% respectively; p<0.0001). The 4 allele presented with a higher frequency in patients (0.15) compared to controls (0.07; p=0282). There were also increases in CT, LDLc and VLDLc serum levels in patients (25965.7; 170.660.1; 38.621.1mg/dL, respectively) in respect to controls 227.542.3; 136.036.9; 30.717.2mg/dL; P<0.0001; P<0.0001; P=0.025 (respectively). The mean concentration of HDLc, on the other hand, was lower in patients (50.212.0 mg/dL) compared to controls (56.516.7 mg/dL; p=0.0091). The mean triglycerides level was higher in patients and controls compared to normal levels (197113.8; 168.093.0, respectively; P=0.056). The lipid profile was not associated to apo E polymorphisms in patients. The control group with -/4 genotypes presented lower triglyceride serous levels in relation to 3/3 (131.249.9; 174.698.6 mg/dL, respectively; P=0.02). There was an increase in the HDLc serous levels of controls compared to patients, when considering the -/4 genotypes. The controls demonstrated significantly lower triglyceride levels (246.0162.8 mg/dL) compared to patients (292.2161.4 mg/dL; P<0.05), 3 to 6 hours after the lipid-rich diet, associated with the -/4 genotypes. In conclusion, FH and SAH are associated with CAD in post-menopausal women. The 4 allele is more prevalent in post-menopausal CAD patients than in control individuals, but it does not influence the lipid profile, however, it exerts a protector effect by its association with high HDLc levels in post-menopausal women without the disease. The triglyceride kinetics, although with similar profiles in both groups, reveal an association between the 4 allele and the accelerated removal of triglycerides only in the control group, suggesting a protector effect in the postprandial stage in post-menopausal women.
publishDate 2004
dc.date.issued.fl_str_mv 2004-05-28
dc.date.accessioned.fl_str_mv 2019-03-07T19:00:20Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv Tácito, Lúcia Helena Bonalume. Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico. 2004. 94 f. Tese (Programa de Pós-Graduação em Ciências da Saúde) - Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto.
dc.identifier.uri.fl_str_mv http://bdtd.famerp.br/handle/tede/524
dc.identifier.doi.por.fl_str_mv 775
identifier_str_mv Tácito, Lúcia Helena Bonalume. Doença arterial coronariano na pós-menopausa: fatores de risco e influência da apolipoproteína E no metabolismo lipídico. 2004. 94 f. Tese (Programa de Pós-Graduação em Ciências da Saúde) - Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto.
775
url http://bdtd.famerp.br/handle/tede/524
dc.language.iso.fl_str_mv por
language por
dc.relation.program.fl_str_mv -6954410853678806574
dc.relation.confidence.fl_str_mv 500
500
600
600
dc.relation.department.fl_str_mv 306626487509624506
dc.relation.cnpq.fl_str_mv -969369452308786627
dc.relation.sponsorship.fl_str_mv -6491868300948288337
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Faculdade de Medicina de São José do Rio Preto
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências da Saúde
dc.publisher.initials.fl_str_mv FAMERP
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade 1::Departamento 1
publisher.none.fl_str_mv Faculdade de Medicina de São José do Rio Preto
dc.source.none.fl_str_mv reponame:Biblioteca Digital de Teses e Dissertações da FAMERP
instname:Faculdade de Medicina de São José do Rio Preto (FAMERP)
instacron:FAMERP
instname_str Faculdade de Medicina de São José do Rio Preto (FAMERP)
instacron_str FAMERP
institution FAMERP
reponame_str Biblioteca Digital de Teses e Dissertações da FAMERP
collection Biblioteca Digital de Teses e Dissertações da FAMERP
bitstream.url.fl_str_mv
http://bdtd.famerp.br/bitstream/tede/524/1/license.txt http://bdtd.famerp.br/bitstream/tede/524/2/L%C3%BAciaHelenaBonalumeT%C3%A1cito_tese.pdf
bitstream.checksum.fl_str_mv bd3efa91386c1718a7f26a329fdcb468
b71731ff47224235ecb9ee7e49a4ef01
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Biblioteca Digital de Teses e Dissertações da FAMERP - Faculdade de Medicina de São José do Rio Preto (FAMERP)
repository.mail.fl_str_mv sbdc@famerp.br||joao.junior@famerp.br
_version_ 1800213988139597824